Antibiotics Market | Expected to Reach USD 39.06 billion (at CAGR of 2.1%) | COVID-19 Impact Covered | Forecast Period 2021-2027

The global “Antibiotics market” size is expected to reach USD 39.06 billion in 2027 at a CAGR of 2.1% during the forecast period. The increasing R&D for the development of antimicrobials in multidrug-resistant bacteria is expected to have a tremendous impact on the global market, states Fortune Business Insights, in a report, titled “Antibiotics Market Size, Share & Industry Analysis, By Drug Class (Cephalosporin, Penicillins, Fluoroquinolones, Macrolides, and Others), By Route of Administration (Oral and Parenteral) By End User (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The market size stood at USD 43.30 billion in 2019.

Major Antibiotics Market Key players covered in the report include:
• Pfizer Inc. (New York, U.S.)
• GlaxoSmithKline plc (Brentford, U.K.)
• Merck & Co., Inc. (New Jersey, U.S.)
• Sandoz (Novartis AG) (Holzkirchen, Germany)
• Daiichi Sankyo Company, Limited (Tokyo, Japan)
• Taisho Pharmaceutical Holdings (Tokyo, Japan)
• Melinta Therapeutics (New Jersey, U.S.)
• Other Prominent Players

Get Request a Sample Copy of the Antibiotics Report:
https://www.fortunebusinessinsights.com/enquiry/sample/antibiotics-market-104583

Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for market to figure out and study the market’s needs, market size, and competition.

Antibiotics Market Analysis 2021:
Market Driver:

Increasing Cases of Bacterial Infections to Boost Market
The increasing cases of bacterial infections will spur demand for antimicrobials, which, in turn, will augur well for the market. The rising incidence of tuberculosis, malaria, pneumonia, bacterial skin infections, urinary tract infections (UTI), and others will bolster the market's healthy growth during the forecast period. As per the estimates of WHO, the worldwide prevalence of tuberculosis was 10 million in 2019. According to the Centers for Disease Control and Prevention, 1.7 million HAIs occur every year in the U.S., 32% of which are hospital-acquired UTIs. The increasing government efforts to prevent hospital-acquired infections (HAI), catheter, and ventilator-associated infections will create lucrative opportunities for the market in the forthcoming years.

Adoption of Digital Health Technologies to Promote Growth Amid Coronavirus
The declined patient volume in standalone clinics and hospitals has forced doctors to adopt digital health technologies to sustain their business. Antibiotics and medical devices companies have incurred huge losses due to the economic crisis caused by the pandemic. Moreover, dopped sales observed by key manufacturers can simultaneously dampen the growth of the market. For instance, nine months of Pfizer’s Zithromax sales decreased by 14.2% in 2020 compared to 2019. Similarly, Cubicin, manufactured by Merck & Co., Inc., witnessed a decline of 44.0% in sale during nine months of 2020 as compared to the previous year

Competitive Landscape:
Substantial R&D Investments by Major Companies to Consolidate Business
Prominent companies such as Merck & Co., Inc, Sandoz, Taisho Pharmaceutical Holdings, Daiichi Sankyo Company, Limited are investing in R&D to strengthen their position in the industry. Moreover, the increasing approvals for innovative therapies by the FDA can spur lucrative opportunities for the market. For instance, in August 2019, TB Alliance, a non-profit organization, received FDA approval for Pretomanid, as part of combination therapy with linezolid and bedaquiline to treat TB.
To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit : https://www.fortunebusinessinsights.com/antibiotics-market-104583

Regional Analysis:
Heavy Demand for Antibiotics to Contribute Growth in Asia Pacific
The market in Asia Pacific is expected to hold the largest share during the forecast period due to the high consumption of antibiotics. According to an article published in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS), China, India, and Pakistan witnessed a rise of 103%, 79%, and 69%, respectively, in antibiotic consumption during 2000-2015. The growing prevalence of bacterial infections coupled with the high use of antimicrobials will spur lucrative opportunities for the Asia Pacific market.

Key Development:
January 2020: Wockhardt announced that it had received approval from The Drug Controller General of India (DCGI) for Emrok (injectable) and Emrok O (oral) in acute bacterial skin and skin structure infections, including diabetic foot infections.

Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/antibiotics-market-104583

Table of Content:

• Introduction
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions

• Executive Summary

• Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities

• Key Insights
o Prevalence of Key Bacterial Infections– For Key Countries/ Regions
o Antimicrobial Resistance Statistics – For Key Countries/ Regions
o Pipeline Snapshot
o New Product Launches
o Key Industry Developments – Partnerships, Mergers, & Acquisitions
o Impact of COVID-19 Pandemic on Antibiotics Market

• Global Antibiotics Market Analysis, Insights and Forecast, 2016-2027
o Key Findings / Summary
o Market Analysis, Insights and Forecast – By Drug Class

Toc Continue…

You can Find an In-depth Analysis on “Antibiotics Market” by Dr Daniel Stewart Here: https://www.linkedin.com/pulse/telemedicine-promising-technology-healthcare-industry-stewart/

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245

This release was published on openPR.